Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSIE: ReoPro and Retavase in Acute Ischemic Stroke
NCT00039832Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Mar 2002
- Primary completion
- Apr 2007
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
A Phase 2 trial of reteplase in ischemic stroke, sponsored by National Institute of Neurological Disorders and Stroke. Started Mar 2002; status: completed.
02
Drugs
reteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00039832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00039832.